She also served as a Peace Corps Volunteer in Benin, West Africa which is where she began her career in public health working on the guinea worm eradication initiative with UNICEF and the Carter Center.
In 2020, she spearheaded the COVID-19 rapid response initiative for the protection and testing of front line workers in Los Angeles and to conduct critical research on SARS-CoV-2 asymptomatic infection, immunity and associated epidemiology.
Her research there has yielded several important discoveries including the emergence of monkeypox since the cessation of smallpox vaccination, and novel strains of Simian foamy virus in humans.
[1] Rimoin's expertise in emerging infectious disease and science communication have made her a regular subject-expert contributor for local, national and international news media outlets.
In print, Rimoin's work has been featured in The New York Times,[7] The Atlantic,[8] Scientific American,[9] Nature[10] and National Geographic as well as more than 100 research articles.